March 29 , 2022
Three new IPOPI PID information leaflets published
Earlier this year IPOPI published three new primary immunodeficiencies (PID) information leaflets:
- Essentials of PID Diagnosis
- Rheumatological, Autoimmune & Autoinflammatory Crossovers
- Targeted Therapies for PIDs
Essentials of PID Diagnosis explains how clinical signs and symptoms, family history, tests and genetic analysis can be used in the diagnosis of primary immunodeficiencies.
Rheumatological, Autoimmune & Autoinflammatory Crossovers explores the crossovers between PIDs and rheumatological, autoimmune and autoinflammatory diseases and how these diseases are managed in patients with PIDs.
Targeted Therapies for PIDs covers how targeted therapy with biological agents or small molecule drugs might be used to treat PIDs.
IPOPI is pleased to make these leaflets available in English and expects newly translated versions to be available soon with invaluable help from national member organisations.
IPOPI wishes to thank Grifols for their support towards the production of these leaflets!